Antibody responses in parvovirus B19 infected patients.
Parvovirus B19 is the causative agent of erythema infectiosum. In addition, the infection may be associated with other disease manifestations: anemia and aplastic crisis, thrombo- or granulocytopenies; spontaneous abortion or hydrops fetalis in pregnant women; acute and chronic arthritis in adults and children, myocarditis and hepatitis. Both acute and persistent courses of B19-infections have been reported. All patients develop IgG against the capsid proteins VP1 and VP2, the majority of virus neutralizing antibodies that offer life-long protection against reinfections are directed against the VP1-unique region. IgM is mainly directed against VP2-specific epitopes. These antibodies may be present for only a rather short period of two to ten weeks after acute infection. IgG-antibodies against the nonstructural protein NS1 are preferentially found in patients which are unable to eliminate the virus and develop persisting viremia or virus persistence in distinct organs, e.g. synovial fluid, liver, bone marrow.
Institut für Medizinische Mikrobiologie, Unversität Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany. susanne.modrow@klinik.uni-regensburg.de
Susanne
S
Modrow
Simone
S
Dorsch
D000914:Antibodies, Viral / Q000097:blood*; D002213:Capsid / Q000276:immunology; D036022:Capsid Proteins; D016731:Erythema Infectiosum / Q000276:immunology / Q000821:virology; D006801:Humans; D010322:Parvoviridae Infections / Q000276:immunology* / Q000821:virology; D016732:Parvovirus B19, Human / Q000235:genetics / Q000276:immunology*; D017361:Viral Nonstructural Proteins / Q000276:immunology
D000914:Antibodies, Viral; D036022:Capsid Proteins; C106202:NS1 protein, parvovirus; D017361:Viral Nonstructural Proteins; C095547:capsid protein VP1, parvovirus B19; C095548:capsid protein VP2, parvovirus B19